Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, announced the appointment of Chuck Alpuche as Chief Operating Officer (COO), Peter Griffin as Senior Vice President of Operations, Scott Elliott as Chief Legal Officer (CLO), and Daniel Davis as Chief Strategy Officer (CSO).
“This is an inflection point of operational scale and excellence for Imperative Care, and we are thrilled to have Chuck lead this important mission,” said Fred Khosravi, Imperative Care’s CEO and Chairman. “Chuck and Peter together have made an indelible impact in elevating the treatment of diabetes, and they will turn their attention to doing the same for stroke and thrombectomy care. Scott brings a wealth of legal and strategic expertise that he has amassed through his very distinguished career advising hypergrowth innovative companies. Daniel will continue his important contributions to the future of patient care with his resolute dedication to meaningful innovation.”
As an accomplished executive leader, Chuck Alpuche brings more than 40 years of senior operational expertise. Prior to joining Imperative Care, he served as the Executive Vice President and COO of Insulet Corporation (NASDAQ: PODD). Previously, he spent 30 years at PepsiCo in leadership roles overseeing domestic and international plant operations. Most recently, he served as PepsiCo’s Senior Vice President of North America Beverages, and also held the position of Vice President and General Manager, Concentrate Operations, Asia and Americas. Alpuche holds a Bachelor of Science in Business Administration from Delaware Valley College and an Executive Master of Science in Organizational Management from the University of Pennsylvania. He serves on the Board of Directors of the L.S. Starrett Company and the non-profit organization, Exceptional Minds.
Peter Griffin joins Imperative Care as a seasoned operations leader with more than 35 years of manufacturing, strategic supplier management, and product development experience. His expertise is in operations management, product development, and supplier management. He most recently held the position of Group Vice President and Chief Procurement Officer at Insulet Corporation, and was previously the global leader of contract manufacturing at Harman International, managing the company’s entire automotive contract manufacturing engagements. He has a Bachelor of Science in Management, Industrial Engineering from Worcester Polytechnic Institute, and a Masters of Business Administration from the F.W. Olin School of Business at Babson College.
Scott Elliott joins the company with over 30 years of experience as a trusted strategic and legal advisor to high-growth companies and investors in various industries, including medical device. Throughout his legal career, he has acted as outside general counsel for companies at various stages and has advised boards of directors on governance issues, public and private financings, mergers and acquisitions, and other strategic transactions. Most recently, he served as a corporate partner at O’Melveny and Myers, LLP in the mergers and acquisitions group, and was Co-Head of the firm’s Life Sciences Practice, where he helped clients structure and negotiate their most meaningful transactions. Elliott holds a Juris Doctor degree from the University of California College of the Law, San Francisco, and a Bachelor of Arts from the University of California, Berkeley.
Daniel Davis will assume the new role of Chief Strategy Officer, overseeing the growth and strategic initiatives of Imperative Care’s businesses. Daniel has played a key role in Imperative Care’s success and is well positioned to help further advance the company’s mission to elevate care, from detection through recovery, for patients with stroke and other devastating vascular diseases.
“We foresee that the knowledge and expertise of these leaders both within and outside of the medical device industry will allow Imperative Care to take the next step forward in our mission to innovate and improve the entire continuum of patient care,” added Khosravi.
SOURCE : BusinessWire